NCT00362037View on ClinicalTrials.gov

I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular Hypertrophy

PHASE4CompletedINTERVENTIONAL

Enrollment

281

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions

Hypertension

Interventions

DRUG

Irbesartan (Aprovel)

Aprovel (150 \& 300mg) \& CoAprovel (300/12.5mg hydrochlorothiazide one per day per os.

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Cairo

Sponsors

Lead Sponsor

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Sanofi

INDUSTRY

NCT00362037 - I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular Hypertrophy | Biotech Hunter | Biotech Hunter